BioAmber Inc. Stock

BIOAQ

US09072Q1067

Delayed OTC Markets 00:58:57 22/11/2019 +04			5-day change	1st Jan Change
0.0525 ^USD	-8.30%		+17.98%	+609.46%

22/10/18	LCY Chemical Corp. and Visolis Inc completed the acquisition of certain assets of BioAmber Inc., BioAmber Canada Inc. and BioAmber Sarnia Inc.	CI
14/09/18	LCY Chemical Corp. and Visolis Inc agreed to acquire certain assets of BioAmber Inc., BioAmber Canada Inc. and BioAmber Sarnia Inc. for $4.3 million.	CI

BioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The Company's technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. Its geographical segments include Europe and North America. Its product pipeline includes the derivatives of bio-succinic acid, such as 1,4 Butanediol (1,4 BDO) and tetrahydrofuran (THF), and succinic acid-based polyesters, and C6 building block chemicals, such as adipic acid, caprolactam and hexamethylenediamine (HMDA). Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.

Employees

Sector

More about the company

Market Cap	958K 834K 790K 717K 1.34M 91.74M 1.35M 9.41M 3.64M 46.62M 3.6M 3.52M 149M	P/E 2016	-7.01x	P/E 2017	-0.17x
Enterprise Value	33.94M 29.56M 27.98M 25.42M 47.49M 3.25B 47.73M 333M 129M 1.65B 128M 125M 5.29B	EV / Sales 2016	24.7x	EV / Sales 2017	3.6x
Free-Float	-	Yield 2016 *	-	Yield 2017	-

22/10/18	LCY Chemical Corp. and Visolis Inc completed the acquisition of certain assets of BioAmber Inc., BioAmber Canada Inc. and BioAmber Sarnia Inc.	CI
14/09/18	LCY Chemical Corp. and Visolis Inc agreed to acquire certain assets of BioAmber Inc., BioAmber Canada Inc. and BioAmber Sarnia Inc. for $4.3 million.	CI
04/09/18	BioAmber Inc. Announces Management Resignations	CI
01/09/18	BioAmber Inc. Announces Resignation of Directors and Officers	CI
30/07/18	BioAmber Updates On Sales Process	CI
20/06/18	BioAmber Inc. Bankruptcy Case Dismissed	CI
30/05/18	Motion for Case Dismissal Filed for BioAmber Inc.	CI
04/05/18	BioAmber Inc. Filed for Bankruptcy	CI
30/03/18	BioAmber Inc. Auditor Raises 'Going Concern' Doubt	CI
28/03/18	BioAmber Inc., Q4 2017 Earnings Call, Mar 28, 2018
27/03/18	BioAmber Inc. Announces Unaudited Consolidated Earnings Results for the Year and Sales Results for the Fourth Quarter Ended December 31, 2017; Announces Impairment for the Fourth Quarter Ended December 31, 2017	CI
13/02/18	BioAmber Inc.(OTCPK:BIOA) dropped from S&P TMI Index	CI
08/11/17	BioAmber Inc., Q3 2017 Earnings Call, Nov 07, 2017

	2016	2017
Net sales	8.27M 7.21M 6.82M 6.2M 11.57M 792M 11.63M 81.22M 31.41M 403M 31.08M 30.38M 1.29B	14.94M 13.02M 12.32M 11.19M 20.91M 1.43B 21.01M 147M 56.73M 727M 56.13M 54.89M 2.33B
Net income	-22.48M -19.58M -18.53M -16.84M -31.45M -2.15B -31.61M -221M -85.34M -1.09B -84.44M -82.56M -3.5B	-98.15M -85.49M -80.91M -73.51M -137M -9.4B -138M -964M -373M -4.78B -369M -361M -15.29B
Net Debt	36.17M 31.51M 29.82M 27.09M 50.61M 3.46B 50.86M 355M 137M 1.76B 136M 133M 5.64B	32.98M 28.73M 27.19M 24.7M 46.15M 3.16B 46.38M 324M 125M 1.61B 124M 121M 5.14B

BioAmber Inc. Stock

Stocks

BIOAQ

US09072Q1067

Valuation: BioAmber Inc.

Latest news: BioAmber Inc.

Quotes and Performance

Financials

Company Profile